| Acular 0.5% w/v Eye Drops, solution PA1824/015/001 |
Ketorolac trometamol |
AbbVie Limited |
Marketed |
| Alphagan 0.2% w/v (2 mg/ml) eye drops, solution PA1824/007/001 |
Brimonidine tartrate |
AbbVie Limited |
Marketed |
| AQUIPTA 10 mg tablets EU/1/23/1750/001-002 |
Atogepant monohydrate |
AbbVie Deutschland GmbH & Co. KG |
— |
| AQUIPTA 60 mg tablets EU/1/23/1750/003-004 |
Atogepant monohydrate |
AbbVie Deutschland GmbH & Co. KG |
— |
| Betagan 0.5% w/v Unit Dose Eye Drops, Solution PA1824/012/001 |
Levobunolol hydrochloride |
AbbVie Limited |
Not marketed |
| BOTOX 100 Allergan Units powder for solution for injection PA1824/017/001 |
Botulinum Toxin Type A |
AbbVie Limited |
Marketed |
| BOTOX 200 Allergan Units powder for solution for injection PA1824/017/003 |
Botulinum Toxin Type A |
AbbVie Limited |
Marketed |
| BOTOX 50 Allergan Units powder for solution for injection PA1824/017/002 |
Botulinum Toxin Type A |
AbbVie Limited |
Marketed |
| Celluvisc 0.5 % w/v eye drops solution, unit dose PA1824/016/002 |
Carmellose sodium |
AbbVie Limited |
Marketed |
| Celluvisc 1% w/v Eye drops, solution, unit dose PA1824/016/001 |
Carmellose sodium |
AbbVie Limited |
Marketed |
| Combigan 2 mg/ml + 5 mg/ml eye drops, solution PA1824/019/001 |
Brimonidine tartrate, Timolol Maleate |
AbbVie Limited |
Not marketed |
| Constella 290 micrograms hard capsules EU/1/12/801/001-004 |
Linaclotide |
AbbVie Deutschland GmbH & Co. KG |
— |
| Duodopa 20 mg/ml + 5 mg/ml intestinal gel PA1824/002/001 |
Levodopa, Carbidopa |
AbbVie Limited |
Marketed |
| EXOCIN (Ofloxacin) 0.3% w/v Eye Drops Solution PA1824/014/001 |
Ofloxacin |
AbbVie Limited |
Marketed |
| FML 0.1% w/v Eye Drops Suspension PA1824/008/001 |
Fluorometholone |
AbbVie Limited |
Not marketed |
| Ganfort 0.3 mg/ml + 5 mg/ml eye drops, solution EU/1/06/340/001-002 |
Bimatoprost, Timolol |
AbbVie Deutschland GmbH & Co. KG |
— |
| Humira 20 mg solution for injection in pre-filled syringe EU/1/03/256/022 |
Adalimumab |
AbbVie Deutschland GmbH & Co. KG |
— |
| Humira 40 mg/0.8 ml solution for injection EU/1/03/256/1-10 |
Adalimumab |
AbbVie Deutschland GmbH & Co. KG |
— |
| Humira 80 mg solution for injection in pre-filled syringe EU/1/03/256/020 |
Adalimumab |
AbbVie Deutschland GmbH & Co. KG |
— |
| Kaletra EU/1/01/172/4-5,7-8 |
Lopinavir, Ritonavir |
AbbVie Deutschland GmbH & Co. KG |
— |
| Kaletra (80 mg + 20 mg)/ml oral solution EU/1/01/172/003 |
Ritonavir, Lopinavir |
AbbVie Deutschland GmbH & Co. KG |
— |
| Kaletra 100 mg/25 mg film-coated tablets EU/1/01/172/006 |
Ritonavir, Lopinavir |
AbbVie Deutschland GmbH & Co. KG |
— |
| Lumigan 0.1 mg/ml eye drops, solution EU/1/02/205/3-4 |
Bimatoprost |
AbbVie Deutschland GmbH & Co. KG |
— |
| Lumigan 0.3 mg/ml eye drops, solution EU/1/02/205/001-2 |
Bimatoprost |
AbbVie Deutschland GmbH & Co. KG |
— |
| Maviret 100 mg/40 mg film-coated tablets EU/1/17/1213/001 |
Pibrentasvir, Glecaprevir |
AbbVie Deutschland GmbH & Co. KG |
— |
| Maviret 50 mg/20 mg coated granules in sachet EU/1/17/1213/003 |
Glecaprevir, Pibrentasvir |
AbbVie Deutschland GmbH & Co. KG |
— |
| Norvir 100 mg film-coated tablets EU/1/96/016/005-006 |
Ritonavir |
AbbVie Deutschland GmbH & Co. KG |
— |
| Norvir 100 mg powder for oral suspension EU/1/96/016/009 |
Ritonavir |
AbbVie Deutschland GmbH & Co. KG |
— |
| OZURDEX 700 micrograms intravitreal implant in applicator EU/1/10/638/001 |
Dexamethasone |
AbbVie Deutschland GmbH & Co. KG |
— |
| Pred Forte 1% w/v, Eye Drops Suspension PA1824/010/001 |
Prednisolone acetate |
AbbVie Limited |
Marketed |
| Pred Mild Sterile Ophthalmic Suspension, 0.12% w/v, Eye Drops, Suspension PA1824/009/001 |
Prednisolone acetate |
AbbVie Limited |
Not marketed |
| Produodopa 240 mg/ml + 12 mg/ml solution for infusion PA1824/002/003 |
Foslevodopa, Foscarbidopa |
AbbVie Limited |
Marketed |
| Relestat, 0.5 mg/ml, eye drops, solution PA1824/018/001 |
Epinastine hydrochloride |
AbbVie Limited |
Not marketed |
| RINVOQ 15 mg prolonged-release tablets EU/1/19/1404/001-005 |
UPADACITINIB, Upadacitinib Hemihydrate |
AbbVie Deutschland GmbH & Co. KG |
— |
| RINVOQ 30 mg prolonged-release tablets EU/1/19/1404/006-009 |
Upadacitinib Hemihydrate |
AbbVie Deutschland GmbH & Co. KG |
— |
| RINVOQ 45 mg prolonged-release tablets EU/1/19/1404/010-011 |
Upadacitinib Hemihydrate |
AbbVie Deutschland GmbH & Co. KG |
— |
| Sevorane 100% v/v Inhalation Gas PA1824/004/001 |
Sevoflurane |
AbbVie Limited |
Marketed |
| Skyrizi 150 mg Solution for injection EU/1/19/1361/003 |
RISANKIZUMAB |
AbbVie Deutschland GmbH & Co. KG |
— |
| Skyrizi 150 mg Solution for injection EU/1/19/1361/002 |
RISANKIZUMAB |
AbbVie Deutschland GmbH & Co. KG |
— |
| Skyrizi 180 mg Solution for injection EU/1/19/1361/007 |
RISANKIZUMAB |
AbbVie Deutschland GmbH & Co. KG |
— |
| Skyrizi 180 mg solution for injection in pre-filled syringe EU/1/19/1361/008-009 |
RISANKIZUMAB |
AbbVie Deutschland GmbH & Co. KG |
— |
| Skyrizi 360 mg Solution for injection EU/1/19/1361/005 |
RISANKIZUMAB |
AbbVie Deutschland GmbH & Co. KG |
— |
| Skyrizi 55 mg solution for injection in pre-filled syringe EU/1/19/1361/010 |
RISANKIZUMAB |
AbbVie Deutschland GmbH & Co. KG |
— |
| Skyrizi 600 mg Concentrate for solution for injection EU/1/19/1361/004 |
RISANKIZUMAB |
AbbVie Deutschland GmbH & Co. KG |
— |
| Skyrizi 75 mg Solution for injection EU/1/19/1361/001 |
RISANKIZUMAB |
AbbVie Deutschland GmbH & Co. KG |
— |
| Skyrizi 90 mg Solution for injection EU/1/19/1361/006 |
RISANKIZUMAB |
AbbVie Deutschland GmbH & Co. KG |
— |
| Tepkinly 4 mg/0.8 ml solution for injection EU/1/23/1759/001 |
Epcoritamab |
AbbVie Deutschland GmbH & Co. KG |
— |
| Tepkinly 48 mg solution for injection EU/1/23/1759/002 |
Epcoritamab |
AbbVie Deutschland GmbH & Co. KG |
— |
| Venclyxto 10 mg film-coated tablets EU/1/16/1138/001-002 |
Venetoclax |
AbbVie Deutschland GmbH & Co. KG |
— |
| Venclyxto 100 mg film-coated tablets EU/1/16/1138/005-007 |
Venetoclax |
AbbVie Deutschland GmbH & Co. KG |
— |